| pubmed-article:16060942 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16060942 | lifeskim:mentions | umls-concept:C0009462 | lld:lifeskim |
| pubmed-article:16060942 | lifeskim:mentions | umls-concept:C0031412 | lld:lifeskim |
| pubmed-article:16060942 | lifeskim:mentions | umls-concept:C0376315 | lld:lifeskim |
| pubmed-article:16060942 | lifeskim:mentions | umls-concept:C0442529 | lld:lifeskim |
| pubmed-article:16060942 | lifeskim:mentions | umls-concept:C0024943 | lld:lifeskim |
| pubmed-article:16060942 | lifeskim:mentions | umls-concept:C0332306 | lld:lifeskim |
| pubmed-article:16060942 | lifeskim:mentions | umls-concept:C2700386 | lld:lifeskim |
| pubmed-article:16060942 | lifeskim:mentions | umls-concept:C0724128 | lld:lifeskim |
| pubmed-article:16060942 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:16060942 | pubmed:dateCreated | 2005-8-2 | lld:pubmed |
| pubmed-article:16060942 | pubmed:abstractText | Epilepsy is a major public-health problem in Africa. The quality of available drugs is a limiting factor for an adequate management. The aim of this study was to describe the proportion of poor-quality phenobarbital (PB) solid-dosage forms and evaluate the factors associated with its quality in Nouakchott (Mauritania). | lld:pubmed |
| pubmed-article:16060942 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16060942 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16060942 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16060942 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16060942 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16060942 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16060942 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16060942 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16060942 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:16060942 | pubmed:issn | 0013-9580 | lld:pubmed |
| pubmed-article:16060942 | pubmed:author | pubmed-author:PreuxPierre-M... | lld:pubmed |
| pubmed-article:16060942 | pubmed:author | pubmed-author:GaulierJean-M... | lld:pubmed |
| pubmed-article:16060942 | pubmed:author | pubmed-author:MerleLouisL | lld:pubmed |
| pubmed-article:16060942 | pubmed:author | pubmed-author:LarocheMarie-... | lld:pubmed |
| pubmed-article:16060942 | pubmed:author | pubmed-author:TraoreHamidou... | lld:pubmed |
| pubmed-article:16060942 | pubmed:author | pubmed-author:VianaMarylene... | lld:pubmed |
| pubmed-article:16060942 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16060942 | pubmed:volume | 46 | lld:pubmed |
| pubmed-article:16060942 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16060942 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16060942 | pubmed:pagination | 1293-6 | lld:pubmed |
| pubmed-article:16060942 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16060942 | pubmed:meshHeading | pubmed-meshheading:16060942... | lld:pubmed |
| pubmed-article:16060942 | pubmed:meshHeading | pubmed-meshheading:16060942... | lld:pubmed |
| pubmed-article:16060942 | pubmed:meshHeading | pubmed-meshheading:16060942... | lld:pubmed |
| pubmed-article:16060942 | pubmed:meshHeading | pubmed-meshheading:16060942... | lld:pubmed |
| pubmed-article:16060942 | pubmed:meshHeading | pubmed-meshheading:16060942... | lld:pubmed |
| pubmed-article:16060942 | pubmed:meshHeading | pubmed-meshheading:16060942... | lld:pubmed |
| pubmed-article:16060942 | pubmed:meshHeading | pubmed-meshheading:16060942... | lld:pubmed |
| pubmed-article:16060942 | pubmed:meshHeading | pubmed-meshheading:16060942... | lld:pubmed |
| pubmed-article:16060942 | pubmed:meshHeading | pubmed-meshheading:16060942... | lld:pubmed |
| pubmed-article:16060942 | pubmed:meshHeading | pubmed-meshheading:16060942... | lld:pubmed |
| pubmed-article:16060942 | pubmed:meshHeading | pubmed-meshheading:16060942... | lld:pubmed |
| pubmed-article:16060942 | pubmed:meshHeading | pubmed-meshheading:16060942... | lld:pubmed |
| pubmed-article:16060942 | pubmed:meshHeading | pubmed-meshheading:16060942... | lld:pubmed |
| pubmed-article:16060942 | pubmed:meshHeading | pubmed-meshheading:16060942... | lld:pubmed |
| pubmed-article:16060942 | pubmed:meshHeading | pubmed-meshheading:16060942... | lld:pubmed |
| pubmed-article:16060942 | pubmed:meshHeading | pubmed-meshheading:16060942... | lld:pubmed |
| pubmed-article:16060942 | pubmed:meshHeading | pubmed-meshheading:16060942... | lld:pubmed |
| pubmed-article:16060942 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16060942 | pubmed:articleTitle | Quality of phenobarbital solid-dosage forms in the urban community of Nouakchott (Mauritania). | lld:pubmed |
| pubmed-article:16060942 | pubmed:affiliation | Institute of Neuroepidemiology and Tropical Neurology (EA 3174), Faculty of Medicine, Limoges, France. | lld:pubmed |
| pubmed-article:16060942 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16060942 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
